I-FABP is linked with intestinal dysfunction and has been identified as a biomarker indicative of increased intestinal permeability, commonly referred to as a ‘leaky gut’, in various intestinal disorders such as necrotizing enterocolitis and inflammatory bowel disease [30,31]. Here, FABP2 is linked to intestinal disorder.